Thursday, March 28, 2019

Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment

A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis.

from Top Health News -- ScienceDaily https://ift.tt/2JGXz5y
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Brain changes in Huntington's disease decades before diagnosis will guide future prevention trials

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before ...